The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Tie2 Receptor Ligands, Angiopoietin-1 and Angiopoietin-2, Modulate VEGF-Induced Postnatal Neovascularization
Open accessAbstract
Abstract —Angiopoietin-1 (Ang1) has been recently identified as the major physiological ligand for the tyrosine kinase receptor Tie2 and assigned responsibility for recruiting and sustaining periendothelial support cells. Angiopoietin-2 (Ang2) was found to disrupt blood vessel formation in the developing embryo by antagonizing the effects of Ang1 and Tie2 and was thus considered to represent a natural Ang1/Tie2 inhibitor. In vivo effects of either angiopoietin on postnatal neovascularization, however, have not been previously described. Accordingly, we used the cornea micropocket assay of neovascularization to investigate the impact of angiopoietins on neovascularization in vivo. Neither Ang1 nor Ang2 alone promoted neovascularization. Pellets containing vascular endothelial growth factor (VEGF) alone induced corneal neovascularity extending from the limbus across the cornea. Addition of Ang1 to VEGF (Ang1+VEGF) produced an increase in macroscopically evident perfusion of the corneal neovasculature without affecting macroscopic measurements of length (0.58±0.03 mm) or circumferential neovascularity (136±10°). In contrast, pellets containing Ang2+VEGF promoted significantly longer (0.67±0.05 mm) and more circumferential (160±15°) neovascularity than VEGF alone or Ang1+VEGF ( P <0.05). Excess soluble Tie2 receptor (sTie2-Fc) precluded modulation of VEGF-induced neovascularization by both Ang2 and Ang1. Fluorescent microscopic findings demonstrated enhanced capillary density (fluorescence intensity, 2.55±0.23 e +9 versus 1.23±0.17 e +9 , P <0.01) and increased luminal diameter of the basal limbus artery (39.0±2.8 versus 27.9±1.3 μm, P <0.01) for Ang1+VEGF compared with VEGF alone. In contrast to Ang1+VEGF, Ang2+VEGF produced longer vessels and, at the tip of the developing capillaries, frequent isolated sprouting cells. In the case of Ang2+VEGF, however, luminal diameter of the basal limbus artery was not increased (26.7±1.9 versus 27.9±1.3, P =NS). These findings constitute what is to our knowledge the first direct demonstration of postnatal bioactivity associated with either angiopoietin. In particular, these results indicate that angiopoietins may potentiate the effects of other angiogenic cytokines. Moreover, these findings provide in vivo evidence that Ang1 promotes vascular network maturation, whereas Ang2 works to initiate neovascularization.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation of Putative Progenitor Endothelial Cells for Angiogenesis
Asahara, T., Murohara, T., Sullivan, A., Silver, M., van der Zee, R., Li, T., Witzenbichler, B., Schatteman, G., & Isner, J. M. (1997) · Science · doi:10.1126/science.275.5302.964 · Cited by 8,725
Self-citationFailure of blood-island formation and vasculogenesis in Flk-1-deficient mice
Shalaby, F., Rossant, J., Yamaguchi, T. P., Gertsenstein, M., Wu, X.-F., Breitman, M. L., & Schuh, A. C. (1995) · Nature · doi:10.1038/376062a0 · Cited by 3,931
Angiopoietin-2, a Natural Antagonist for Tie2 That Disrupts in vivo Angiogenesis
Maisonpierre, P. C., Suri, C., Jones, P. F., Bartunkova, S., Wiegand, S. J., Radziejewski, C., Compton, D., McClain, J., Aldrich, T. H., Papadopoulos, N., et al. (1997) · Science · doi:10.1126/science.277.5322.55 · Cited by 3,570
Self-citationRequisite Role of Angiopoietin-1, a Ligand for the TIE2 Receptor, during Embryonic Angiogenesis
Suri, C., Jones, P. F., Patan, S., Bartunkova, S., Maisonpierre, P. C., Davis, S., Sato, T. N., & Yancopoulos, G. D. (1996) · Cell · doi:10.1016/s0092-8674(00)81813-9 · Cited by 2,847
Self-citationRole of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium
Fong, G.-H., Rossant, J., Gertsenstein, M., & Breitman, M. L. (1995) · Nature · doi:10.1038/376066a0 · Cited by 2,606
Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation
Sato, T. N., Tozawa, Y., Deutsch, U., Wolburg-Buchholz, K., Fujiwara, Y., Gendron-Maguire, M., Gridley, T., Wolburg, H., Risau, W., & Qin, Y. (1995) · Nature · doi:10.1038/376070a0 · Cited by 1,820
Signaling Vascular Morphogenesis and Maintenance
Hanahan, D. (1997) · Science · doi:10.1126/science.277.5322.48 · Cited by 1,190
Takeshita, S., Zheng, L. P., Brogi, E., Kearney, M., Pu, L. Q., Bunting, S., Ferrara, N., Symes, J. F., & Isner, J. M. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117018 · Cited by 1,036
Self-citationIsner, J. M., Pieczek, A., Schainfeld, R., Blair, R., Haley, L., Asahara, T., Rosenfield, K., Razvi, S., Walsh, K., & Symes, J. F. (1996) · The Lancet · doi:10.1016/s0140-6736(96)03361-2 · Cited by 989
Self-citationDumont, D. J., Gradwohl, G., Fong, G. H., Puri, M. C., Gertsenstein, M., Auerbach, A., & Breitman, M. L. (1994) · Genes & Development · doi:10.1101/gad.8.16.1897 · Cited by 985
Cited by
Takahashi, T., Kalka, C., Masuda, H., Chen, D., Silver, M., Kearney, M., Magner, M., Isner, J. M., & Asahara, T. (1999) · Nature Medicine · doi:10.1038/7434 · Cited by 2,423
Self-citationAsahara, T., Takahashi, T., Masuda, H., Kalka, C., Chen, D., Iwaguro, H., Inai, Y., Silver, M., & Isner, J. M. (1999) · The EMBO Journal · doi:10.1093/emboj/18.14.3964 · Cited by 1,856
Self-citationPI3K/AKT/mTOR Pathway in Angiogenesis
Karar, J., & Maity, A. (2011) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2011.00051 · Cited by 1,461
Current concepts in the pathogenesis of age-related macular degeneration
Zarbin, M. A. (2004) · Archives of Ophthalmology · doi:10.1001/archopht.122.4.598 · Cited by 1,006
“Also, ECM molecules can stimulate or inhibit angiogenesis by binding to integrins or by altering integrin expression on endothelial cells (Table 3).(204,209,219,222,223) Matrix metalloproteinases and urokinase plasminogen activator break down the ECM during angiogenesis.”
Clinical applications of angiogenic growth factors and their inhibitors
Ferrara, N., & Alitalo, K. (1999) · Nature Medicine · doi:10.1038/70928 · Cited by 1,004
Oh, S. P., Seki, T., Goss, K. A., Imamura, T., Yi, Y., Donahoe, P. K., Li, L., Miyazono, K., ten Dijke, P., Kim, S., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.6.2626 · Cited by 851
Griffioen, A. W., & Molema, G. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01448-0 · Cited by 842
Role of vascular endothelial growth factor in the regulation of angiogenesis
Ferrara, N. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00610.x · Cited by 731
Klaassen, I., Van Noorden, C. J. F., & Schlingemann, R. O. (2013) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2013.02.001 · Cited by 722
HMG-CoA reductase inhibitor mobilizes bone marrow–derived endothelial progenitor cells
Llevadot, J., Murasawa, S., Kureishi, Y., Uchida, S., Masuda, H., Kawamoto, A., Walsh, K., Isner, J. M., & Asahara, T. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13131 · Cited by 709
Self-citationAkt in cancer: Mediator and more
Revathidevi, S., & Munirajan, A. K. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.06.002 · Cited by 691
Lobov, I. B., Brooks, P. C., & Lang, R. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.172161899 · Cited by 676
Pola, R., Ling, L. E., Silver, M., Corbley, M. J., Kearney, M., Blake Pepinsky, R., Shapiro, R., Taylor, F. R., Baker, D. P., Asahara, T., et al. (2001) · Nature Medicine · doi:10.1038/89083 · Cited by 612
Self-citationAngiopoietins: a link between angiogenesis and inflammation
Fiedler, U., & Augustin, H. G. (2006) · Trends in Immunology · doi:10.1016/j.it.2006.10.004 · Cited by 606
Yoon, Y.-S., Wecker, A., Heyd, L., Park, J.-S., Tkebuchava, T., Kusano, K., Hanley, A., Scadova, H., Qin, G., Cha, D.-H., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200522326 · Cited by 585
Self-citationFazel, S. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27019 · Cited by 517
A Role for Hematopoietic Stem Cells in Promoting Angiogenesis
Takakura, N., Watanabe, T., Suenobu, S., Yamada, Y., Noda, T., Ito, Y., Satake, M., & Suda, T. (2000) · Cell · doi:10.1016/s0092-8674(00)00025-8 · Cited by 506
Oh, H., Takagi, H., Suzuma, K., Otani, A., Matsumura, M., & Honda, Y. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.22.15732 · Cited by 499
Signaling and Functions of Angiopoietin-1 in Vascular Protection
Brindle, N. P. J., Saharinen, P., & Alitalo, K. (2006) · Circulation Research · doi:10.1161/01.res.0000218275.54089.12 · Cited by 487
Hypoxia, mitochondrial dysfunction and synovial invasiveness in rheumatoid arthritis
Fearon, U., Canavan, M., Biniecka, M., & Veale, D. J. (2016) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2016.69 · Cited by 439
Vasculogenesis and Angiogenesis
Patan, S. (2004) · Cancer Treatment and Research · doi:10.1007/978-1-4419-8871-3_1 · Cited by 430
Tie receptors: new modulators of angiogenic and lymphangiogenic responses
Jones, N., Iljin, K., Dumont, D. J., & Alitalo, K. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35067005 · Cited by 418
The Tunica Adventitia of Human Arteries and Veins As a Source of Mesenchymal Stem Cells
Corselli, M., Chen, C.-W., Sun, B., Yap, S., Rubin, J. P., & Péault, B. (2012) · Stem Cells and Development · doi:10.1089/scd.2011.0200 · Cited by 393
“The same outcome was observed when adventitial cells were treated with angiopoietin-2, a growth factor produced at the site of vascular re-modeling that disrupts interactions between smooth muscle cells and endothelial cells, thus leading to angiogenesis in the presence of VEGF [38].”
Fukuhara, S., Sako, K., Minami, T., Noda, K., Kim, H. Z., Kodama, T., Shibuya, M., Takakura, N., Koh, G. Y., & Mochizuki, N. (2008) · Nature Cell Biology · doi:10.1038/ncb1714 · Cited by 387
Vasculogenesis and Angiogenesis as Mechanisms of Vascular Network Formation, Growth and Remodeling
Patan, S. (2000) · Journal of Neuro-Oncology · doi:10.1023/a:1006493130855 · Cited by 382
Regula, J. T., Lundh von Leithner, P., Foxton, R., Barathi, V. A., Cheung, C. M. G., Bo Tun, S. B., Wey, Y. S., Iwata, D., Dostalek, M., Moelleken, J., et al. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201505889 · Cited by 376
Mathematical modeling of tumor-induced angiogenesis
Mantzaris, N. V., Webb, S., & Othmer, H. G. (2004) · Journal of Mathematical Biology · doi:10.1007/s00285-003-0262-2 · Cited by 362
Tie receptors and their angiopoietin ligands are context-dependent regulators of vascular remodeling
EKLUND, L., & OLSEN, B. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.09.002 · Cited by 343
Yamakawa, M., Liu, L. X., Date, T., Belanger, A. J., Vincent, K. A., Akita, G. Y., Kuriyama, T., Cheng, S. H., Gregory, R. J., & Jiang, C. (2003) · Circulation Research · doi:10.1161/01.res.0000093984.48643.d7 · Cited by 327
The pregnant sheep as a model for human pregnancy
Barry, J. S., & Anthony, R. V. (2008) · Theriogenology · doi:10.1016/j.theriogenology.2007.09.021 · Cited by 315
The inner blood-retinal barrier: Cellular basis and development
Díaz-Coránguez, M., Ramos, C., & Antonetti, D. A. (2017) · Vision Research · doi:10.1016/j.visres.2017.05.009 · Cited by 314
Reversal of experimental diabetic neuropathy by VEGF gene transfer
Schratzberger, P., Walter, D. H., Rittig, K., Bahlmann, F. H., Pola, R., Curry, C., Silver, M., Krainin, J. G., Weinberg, D. H., Ropper, A. H., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12188 · Cited by 310
Self-citationKim, I., Kim, J.-H., Moon, S.-O., Kwak, H. J., Kim, N.-G., & Koh, G. Y. (2000) · Oncogene · doi:10.1038/sj.onc.1203800 · Cited by 306
Teichert-Kuliszewska, K. (2001) · Cardiovascular Research · doi:10.1016/s0008-6363(00)00231-5 · Cited by 291
Altered angiogenesis and survival in human tumor‐derived endothelial cells
Bussolati, B., Deambrosis, I., Russo, S., Deregibus, M. C., & Camussi, G. (2003) · The FASEB Journal · doi:10.1096/fj.02-0557fje · Cited by 288
Matsumura, G., Miyagawa-Tomita, S., Shin’oka, T., Ikada, Y., & Kurosawa, H. (2003) · Circulation · doi:10.1161/01.cir.0000092165.32213.61 · Cited by 275
Murayama, T., Tepper, O. M., Silver, M., Ma, H., Losordo, D. W., Isner, J. M., Asahara, T., & Kalka, C. (2002) · Experimental Hematology · doi:10.1016/s0301-472x(02)00867-6 · Cited by 268
Self-citationCardiovascular ephrinB2 function is essential for embryonic angiogenesis
Gerety, S. S., & Anderson, D. J. (2002) · Development · doi:10.1242/dev.129.6.1397 · Cited by 263
Endothelial progenitor cells in neovascularization of infarcted myocardium
Jujo, K., Ii, M., & Losordo, D. W. (2008) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2008.08.003 · Cited by 262
Akt Takes Center Stage in Angiogenesis Signaling
Dimmeler, S., & Zeiher, A. M. (2000) · Circulation Research · doi:10.1161/01.res.86.1.4 · Cited by 260
COMP-Ang1: A designed angiopoietin-1 variant with nonleaky angiogenic activity
Cho, C.-H., Kammerer, R. A., Lee, H. J., Steinmetz, M. O., Ryu, Y. S., Lee, S. H., Yasunaga, K., Kim, K.-T., Kim, I., Choi, H.-H., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307574101 · Cited by 257
Camenisch, G., Pisabarro, M. T., Sherman, D., Kowalski, J., Nagel, M., Hass, P., Xie, M.-H., Gurney, A., Bodary, S., Liang, X. H., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109768200 · Cited by 253
Cascone, I., Napione, L., Maniero, F., Serini, G., & Bussolino, F. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200507082 · Cited by 179
The blood-retinal barrier: structure and functional significance
Runkle, E. A., & Antonetti, D. A. (2011) · Methods in Molecular Biology · doi:10.1007/978-1-60761-938-3_5 · Cited by 171
Wada, H., Nagano, H., Yamamoto, H., Yang, Y., Kondo, M., Ota, H., Nakamura, M., Yoshioka, S., Kato, H., Damdinsuren, B., et al. (2006) · Liver International · doi:10.1111/j.1478-3231.2006.01243.x · Cited by 130
Arsic, N., Zentilin, L., Zacchigna, S., Santoro, D., Stanta, G., Salvi, A., Sinagra, G., & Giacca, M. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(03)00034-0 · Cited by 108
Activated protein C utilizes the angiopoietin/Tie2 axis to promote endothelial barrier function
Minhas, N., Xue, M., Fukudome, K., & Jackson, C. J. (2010) · The FASEB Journal · doi:10.1096/fj.09-134445 · Cited by 94
Advanced Glycation End Products Induce Angiogenesis in Vivo
Okamoto, T., Tanaka, S., Stan, A. C., Koike, T., Kase, M., Makita, Z., Sawa, H., & Nagashima, K. (2002) · Microvascular Research · doi:10.1006/mvre.2001.2371 · Cited by 47
Wang, H.-L., Deng, C.-S., Lin, J., Pan, D.-Y., Zou, Z.-Y., & Zhou, X.-Y. (2007) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.213.33 · Cited by 23
“Asahara et al. (1998) reported that Ang-2 may cooperate with VEGF in enhancing the formation of blood vessel net, thereby improving the recovery of damaged vessels and maintaining them in a plastic condition.”
Background
Metadata
- Authors
- Asahara, T., Chen, D., Takahashi, T., Fujikawa, K., Kearney, M., Magner, M., Yancopoulos, G. D., & Isner, J. M.
- Venue
- Circulation Research
- Published
- 1998-08-10
- Volume
- 83
- Issue
- 3
- Pages
- 233-240
- ISSN
- 0009-7330 (ISSN-L)
- 1524-4571
- OpenAlex
- W2078348571
- Cited by
- 683
- References
- 25
- FWCI
- 10.24
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.